Groundbreaking research finds dropping the third stage of standard MRI test for the disease doesn’t hamper detection rates, and cuts costs in half
Cutting the duration of MRI scans for prostate cancer by a third would make them cheaper and more accessible without reducing their accuracy. That is the key result of a UK trial which indicates that lowering costs could ensure more men are offered scans.
According to Cancer Research UK, there are about 52,300 new prostate cancer cases every year in the UK, equal to more than 140 a day.
About Author
More Stories
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
The deadliest beings on the planet: can the bacteriophage help in our fight against superbugs?
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton